Ironwood Pharmaceuticals (IRWD) Capital Expenditures Growth (3y) (2013 - 2025)
Ironwood Pharmaceuticals (IRWD) Capital Expenditures Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.16 Bn | 1.97 Bn | 6.52% |
| 3 | Zoetis | 32.46 Bn | 30.52 Bn | 1.62 Bn | 232.22% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | 1.64% |
| 5 | United Therapeutics | 23.13 Bn | 20.98 Bn | 648.10 Mn | 75.58% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn | -5.84% |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn | 32.64% |
| 9 | Elanco Animal Health | 12.60 Bn | 12.18 Bn | 785.00 Mn | 28.56% |
| 10 | Ironwood Pharmaceuticals | 644.81 Mn | 424.34 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 66.67% |
| Sep 30, 2025 | -68.82% |
| Jun 30, 2025 | -71.67% |
| Mar 31, 2025 | 51.02% |
| Dec 31, 2023 | 96.05% |
| Mar 31, 2023 | -79.17% |
| Dec 31, 2022 | 79.72% |
| Sep 30, 2022 | -72.22% |
| Jun 30, 2022 | -66.92% |
| Mar 31, 2022 | 26.18% |
| Dec 31, 2021 | -20.42% |
| Dec 31, 2020 | 27.42% |
| Jun 30, 2020 | -19.06% |
| Mar 31, 2020 | 11.51% |
| Dec 31, 2019 | -67.55% |
| Sep 30, 2019 | 30.48% |
| Jun 30, 2019 | 58.14% |
| Mar 31, 2019 | -43.91% |
| Sep 30, 2018 | -34.16% |
| Jun 30, 2018 | -27.50% |